Indivior PLC Ordinary Shares

INDV · Moat type: REGULIERUNG

MoatScore

6/10

Fair Value

78 USD

Margin of Safety

+48.1 %

Rating

BEOBACHTEN

Indivior is a pharmaceutical company specialized in addiction medicine that generates revenues primarily through patent-protected medications for treating opioid dependence (particularly buprenorphine formulations).

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.